ES2062094T3 - Derivados del acido parabanico y composiciones farmaceuticas que los contienen. - Google Patents

Derivados del acido parabanico y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2062094T3
ES2062094T3 ES89810582T ES89810582T ES2062094T3 ES 2062094 T3 ES2062094 T3 ES 2062094T3 ES 89810582 T ES89810582 T ES 89810582T ES 89810582 T ES89810582 T ES 89810582T ES 2062094 T3 ES2062094 T3 ES 2062094T3
Authority
ES
Spain
Prior art keywords
derivatives
contain
pharmaceutical compositions
parabanic acid
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89810582T
Other languages
English (en)
Inventor
Akira Institute Of Bio-A Ishii
Masahiro Institute Of Yamakawa
Yoshio Institute Of B Toyomaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2062094T3 publication Critical patent/ES2062094T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE ACIDO PARABANICO Y SUS SALES Y COMPLEJOS METALICOS FARMACEUTICAMENTE ACEPTABLES, QUE TIENEN ACTIVIDAD INHIBIDORA DE LA REDUCTASA DE ALDOSA. LOS COMPUESTOS TIENEN LA FORMULA (I). LOS COMPUESTOS SON UTILES COMO MEDICAMENTOS PARA EL TRATAMIENTO O PREVENCION DE CONDICIONES DIABETICA.
ES89810582T 1988-07-29 1989-07-28 Derivados del acido parabanico y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2062094T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63190921A JP2544183B2 (ja) 1988-07-29 1988-07-29 新規パラバン酸誘導体及び該化合物を有効成分として含有する医薬組成物

Publications (1)

Publication Number Publication Date
ES2062094T3 true ES2062094T3 (es) 1994-12-16

Family

ID=16265915

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89810582T Expired - Lifetime ES2062094T3 (es) 1988-07-29 1989-07-28 Derivados del acido parabanico y composiciones farmaceuticas que los contienen.

Country Status (6)

Country Link
US (1) US4985453A (es)
EP (1) EP0353198B1 (es)
JP (1) JP2544183B2 (es)
AT (1) ATE101138T1 (es)
DE (1) DE68912843T2 (es)
ES (1) ES2062094T3 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681843A (en) * 1994-12-20 1997-10-28 Nippon Zoki Pharmaceutical Co., Ltd. Parabanic acid derivatives
US5912261A (en) * 1994-12-20 1999-06-15 Nippon Zoki Pharmaceutical Co., Ltd. Carboxyalkyl heterocyclic derivatives
US6197806B1 (en) 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
WO1997049686A1 (en) * 1996-06-24 1997-12-31 Cytec Technology Corp. Novel polymerizable acyl imidazolidinone monomers
JPH10182460A (ja) * 1996-12-27 1998-07-07 Nippon Zoki Pharmaceut Co Ltd ３−デオキシグルコソン生成阻害剤
AU754989B2 (en) 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
US6251829B1 (en) 2000-04-18 2001-06-26 Rohm And Haas Company Herbicidal benzoyloxy carboxylates and carboxamides
US6444615B1 (en) * 2000-04-18 2002-09-03 Dow Agrosciences Llc Herbicidal imidazolidinetrione and thioxo-imidazolidinediones
JP4711523B2 (ja) 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
US20060241163A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (S)-hydantoin derivative
US20060241162A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (R)-hydantoin derivative

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB807678A (en) * 1956-01-16 1959-01-21 Harold Crowther Brimelow New substituted hydantoins and thiohydantoins
US3766202A (en) * 1969-08-22 1973-10-16 Chevron Res 1,3-disubstituted-5-(substituted thio) imino-2,4-imidazolidine-dionesand the 4-thio analogs
DD219483A1 (de) * 1983-11-17 1985-03-06 Rainer Beckert Verfahren zur herstellung von 1-carbethoxymethyl- und 1-carbethoxyethyl-imidazolidinen
ATE50248T1 (de) * 1985-02-06 1990-02-15 Nippon Zoki Pharmaceutical Co Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.

Also Published As

Publication number Publication date
JPH0240368A (ja) 1990-02-09
DE68912843T2 (de) 1994-06-30
JP2544183B2 (ja) 1996-10-16
DE68912843D1 (de) 1994-03-17
US4985453A (en) 1991-01-15
EP0353198A1 (en) 1990-01-31
ATE101138T1 (de) 1994-02-15
EP0353198B1 (en) 1994-02-02

Similar Documents

Publication Publication Date Title
PT92437A (pt) Processo de preparacao de derivados da quinazolinona, dos seus intermediarios e de composicoes farmaceuticas que os contem
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
MX173630B (es) Derivados de aminoacido, procedimiento para su preparacion y su preparacion y medicamento que los contiene
NL960019I1 (nl) Moforlino-ethylester van mycofenolzuur en derivaten ervan, de bereiding ervan en hun toepassing in farmaceutische samenstellingen.
NO822725L (no) Antiviralforbindelser.
LU90839I2 (fr) Kaletra-combinaison de lopinavir et de ritonavir et ses d-riv-s pharmaceutiquement acceptables
BR0014137A (pt) Composto, método para inibir a aurora 2 quinase em um animal de sangue quente, uso de um composto, e, composição farmacêutica
NO890723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-alkenyl-1-azabicyklo(3.2.0)hept2-en-2-karboksylsyrederivater.
ES2062094T3 (es) Derivados del acido parabanico y composiciones farmaceuticas que los contienen.
FI895669A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 3,5-di-tert-butyyli-4-hydroksifenyylisubstituoitujen 1,2,4- ja 1,3,4-tiadiatsolien sekä oksadiatsolien ja triatsolien valmistamiseksi
RU94038256A (ru) Производные пиразолопиримидина, способ их получения, фармацевтические композиции на их основе
ES538847A0 (es) Un derivado de fenilserina
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
NO881835L (no) Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
DE69212331D1 (de) Imidazole derivate und diese enthaltende arzneimittel
DK521685A (da) Spergualin-derivater og anvendelse deraf til fremstilling af laegemidler med immunosuppressiv virkning
DK0541407T3 (da) Nitrogenholdige, bicykliske derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem
FR2701260B1 (fr) Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments.
DK0911026T3 (da) Creatinderivater for astma
ATE13423T1 (de) Guanidinderivate und diese enthaltende pharmazeutische zusammensetzungen.
PT92389A (pt) Processo para a preparacao de derivados heterociclicos fundidos da 1,2,3,4- - tetrahidroacridina e de composicoes farmaceuticas que os contem
FR2433943A1 (fr) Preparations medicamenteuses notamment pour le traitement de l'hypercholesterolemie
PT98186A (pt) Processo para a preparacao de purinil- e de pirimidinil-tetra-hidrofuranos e de composicoes farmaceuticas que os contem
ES528457A0 (es) Procedimiento de preparacion de nuevos derivados benzohidrilpiperacinos y sus sales de adicion acidas
BR9206978A (pt) Composição farmacêutica para inibir infecção com vírus da aids

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 353198

Country of ref document: ES